These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29961742)

  • 1. The Changes of CTX, DPD, Osteocalcin, and Bone Mineral Density During the Postmenopausal Period.
    Park SG; Jeong SU; Lee JH; Ryu SH; Jeong HJ; Sim YJ; Kim DK; Kim GC
    Ann Rehabil Med; 2018 Jun; 42(3):441-448. PubMed ID: 29961742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
    Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
    Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone turnover markers in postmenopausal osteoporosis and their correlation with bone mineral density and menopause duration.
    Gurban CV; Balaş MO; Vlad MM; Caraba AE; Jianu AM; Bernad ES; Borza C; Bănicioiu-Covei S; Motoc AGM
    Rom J Morphol Embryol; 2019; 60(4):1127-1135. PubMed ID: 32239087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study.
    Qu XL; Zheng B; Chen TY; Cao ZR; Qu B; Jiang T
    Orthop Surg; 2020 Feb; 12(1):116-123. PubMed ID: 31880071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial.
    Mawatari T; Ikemura S; Matsui G; Iguchi T; Mitsuyasu H; Kawahara S; Maehara M; Muraoka R; Iwamoto Y; Nakashima Y
    Bone Rep; 2020 Jun; 12():100275. PubMed ID: 32462056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
    Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of long chain polyunsaturated fatty acids with bone mineral density and bone turnover in postmenopausal women.
    Feehan O; Magee PJ; Pourshahidi LK; Armstrong DJ; Slevin MM; Allsopp PJ; Conway MC; Strain JJ; McSorley EM
    Eur J Nutr; 2023 Feb; 62(1):95-104. PubMed ID: 35908118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods.
    Wang J; Yan D; Zhao A; Hou X; Zheng X; Chen P; Bao Y; Jia W; Hu C; Zhang ZL; Jia W
    Osteoporos Int; 2019 Jul; 30(7):1491-1499. PubMed ID: 30778642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.
    Garnero P; Mulleman D; Munoz F; Sornay-Rendu E; Delmas PD
    J Bone Miner Res; 2003 Oct; 18(10):1789-94. PubMed ID: 14584889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.
    Lai PS; Chua SS; Chew YY; Chan SP
    J Clin Pharm Ther; 2011 Oct; 36(5):557-67. PubMed ID: 21916908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I.
    Reginster JY; Henrotin Y; Christiansen C; Gamwell-Henriksen E; Bruyere ; Collette J; Christgau S
    Calcif Tissue Int; 2001 Sep; 69(3):130-7. PubMed ID: 11683527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalassemic osteopathy: a new marker of bone deposition.
    Baldini M; Forti S; Orsatti A; Marcon A; Ulivieri FM; Airaghi L; Zanaboni L; Cappellini MD
    Blood Cells Mol Dis; 2014; 52(2-3):91-4. PubMed ID: 24091145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy.
    Fink E; Cormier C; Steinmetz P; Kindermans C; Le Bouc Y; Souberbielle JC
    Osteoporos Int; 2000; 11(4):295-303. PubMed ID: 10928218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
    Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.